CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Radiation Neuropathy
University Hospital, GhentSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Radiation Neuropathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE British Columbia Cancer Agency | Phase 3 | BB |
Same molecule, other indications
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →